News

Nectar Lifesciences soars around 20%, hits 52-week low after announcing ₹1,270 crore biz sale to Ceph Lifesciences
Nectar Lifesciences Ltd. shares fell nearly 20% to ₹18.60 after announcing the sale of its API and formulations business to ...
Colin Egglesfield Recalls ‘Overwhelming’ Journey Facing Cancer a 3rd Time: ‘I’m Not Backing Away from This’ (Exclusive)
More than a decade after beating testicular cancer twice, Colin Egglesfield was diagnosed with prostate cancer. The ...